Chowdhury, S., Bryce, A. H., Fizazi, K., Saez, M. I., Redfern, C. H., Benjelloun, A., Burke, J. M., Campbell, D. C., Fléchon, A., Malik, Z., Reid, A. H., Santis, M. D., Graff, J. N., Koshkin, V. S., Pinto, A., Fontana, E., Rosenbaum, E., Connor, C., Peynado, M., Ryan, C. J. (2025). Impact of germline vs somatic BRCA mutation status on the efficacy of rucaparib vs physician’s choice in the TRITON3 study of patients with metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.5060